Vidaza and atrial fibrillation Patient Reports February 11, 2012

Vidaza Side Effects Report #4648977-3
Vidaza side effect was reported by a Physician from on Apr 12, 2005. Male patient, 81 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: atrial fibrillation , atrial flutter, febrile neutropenia, hypercapnia, hyperglycaemia, renal failure acute, respiratory failure, white blood cell count decreased. Vidaza dosage: unknown. During the same period patient was treated with THALOMID. Patient was hospitalized. Patient died on 11/29/2004.

Vidaza Side Effects Report #4867941-2
Vidaza side effect was reported by a Physician from SWITZERLAND on Dec 16, 2005. Male patient, 81 years of age, weighting 172.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: aortic arteriosclerosis, atrial fibrillation , cerebrovascular accident, condition aggravated, confusional state, embolism, fall , performance status decreased, renal impairment. Vidaza dosage: 120 MG (120 MG, ONCE DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with ATENOLOL, TORASEMIDE, FOLIC ACID. Patient was hospitalized. Patient recovered.

Vidaza Side Effects Report #6044426-1
Vidaza side effect was reported by a Health Professional from UNITED STATES on Jan 15, 2009. Male patient, 71 years of age, weighting 191.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: atelectasis, atrial fibrillation , blood magnesium decreased, cardiac failure congestive, cardiomegaly, condition aggravated, dyspnoea, ejection fraction decreased, fatigue. Vidaza dosage: 108MG EVERY OTHER DAY, X2WEEKS Q4WEEKS : SUBCUTANEOUS. Patient was hospitalized. Patient recovered.

Vidaza Side Effects Report #5443288-0
Vidaza side effect was reported by a Physician from GERMANY on Aug 16, 2007. Male patient, 59 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: anaemia, aplasia, atrial fibrillation , catheter site haemorrhage, convulsion, febrile neutropenia, haemoptysis, left ventricular failure. Vidaza dosage: (100 MG/M2), SUBCUTANEOUS. During the same period patient was treated with VALPROIC ACID, NEUPOGEN. Patient was hospitalized. Patient died on 07/15/2007.


Vidaza Side Effects Report #4811535-1
Vidaza side effect was reported by a Physician from POLAND on Oct 10, 2005. Female patient, 53 years of age, weighting 130.1 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: abdominal distension, acute pulmonary oedema, anaemia, asthenia, atrial fibrillation , blood glucose increased, cardiogenic shock, gastrointestinal haemorrhage. Vidaza dosage: 100 MG (DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with ENCORTON, POLPRAZOL, DIAPREL, HEMOROL, PROPRANOLOL, ENALAPRIL MALEATE, SPIRONOL, FLUCONAZOLE. Patient was hospitalized. Patient died on 10/03/2005.

Vidaza Side Effects Report #5213880-7
Vidaza side effect was reported by a Physician from UNITED STATES on Jan 05, 2007. Female patient, 55 years of age, weighting 177.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: atrial fibrillation , culture urine positive, enterococcal infection, neutropenic sepsis, no therapeutic response, pericardial effusion, pericarditis, sinus tachycardia, staphylococcal infection . Vidaza dosage: 132.75 MG (75 MG/M2, DAILY X 7 DAYS, SUBCUTANEOUS. During the same period patient was treated with MGCD, FLAGYL, ACYCLOVIR, LEVAQUIN, VORICONAZOLE, COLACE, BENAZEPRIL. Patient was hospitalized. Patient died on 01/08/2007.

Vidaza Side Effects Report #5228738-7
Vidaza side effect was reported by a Physician from UNITED STATES on Jan 19, 2007. Female patient, 55 years of age, weighting 177.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: atrial fibrillation , cardiopulmonary failure, culture urine positive, enterococcal infection, hypotension, neutropenic sepsis, no therapeutic response, pericarditis, sinus tachycardia. Vidaza dosage: 132.75 MG (75 MG/M2,DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with MGCD, FLAGYL, ACYCLOVIR, LEVAQUIN, VORICONAZOLE, COLACE, BENAZEPRIL HYDROCHLORIDE. Patient was hospitalized. Patient died on 01/08/2007.